RESULTS

Cancer metabolism challenges genomic instability and clonal evolution as therapeutic targets (Cancer Science, 2022)

In the collaboration with Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Japan (Professors Eguchi and Doki) and academia-industry collaboration with Idea Consults, Inc., Osaka, Dr. Takeda has focused on the mechanism of cancer metabolism, which is involved in genomic instability, mutations, and evolution of damaged cell clones. The study will be emerged to be important as the innovation and discovery of diagnostic and therapeutic, novel targets.